A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Legend Biotech Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 29,300 shares of LEGN stock, worth $1.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,300
Previous 22,000 33.18%
Holding current value
$1.26 Million
Previous $974,000 46.51%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$43.55 - $59.88 $5.59 Million - $7.68 Million
-128,309 Reduced 8.88%
1,316,554 $64.2 Million
Q2 2024

Aug 14, 2024

BUY
$39.5 - $57.22 $11.9 Million - $17.2 Million
300,387 Added 26.25%
1,444,863 $64 Million
Q1 2024

May 15, 2024

BUY
$55.06 - $69.99 $53.9 Million - $68.5 Million
978,545 Added 589.73%
1,144,476 $64.2 Million
Q4 2023

Feb 14, 2024

BUY
$57.25 - $69.74 $8.27 Million - $10.1 Million
144,476 Added 673.39%
165,931 $9.98 Million
Q3 2023

Nov 14, 2023

SELL
$63.16 - $76.5 $1.1 Million - $1.33 Million
-17,357 Reduced 44.72%
21,455 $1.44 Million
Q2 2023

Aug 14, 2023

BUY
$46.28 - $75.01 $1.46 Million - $2.36 Million
31,511 Added 431.6%
38,812 $2.68 Million
Q1 2023

May 15, 2023

SELL
$43.42 - $57.37 $1.05 Million - $1.39 Million
-24,192 Reduced 76.82%
7,301 $352,000
Q4 2022

Feb 14, 2023

SELL
$38.8 - $55.46 $8.8 Million - $12.6 Million
-226,783 Reduced 87.81%
31,493 $1.57 Million
Q3 2022

Nov 14, 2022

BUY
$38.15 - $57.1 $5.24 Million - $7.85 Million
137,467 Added 113.79%
258,276 $10.5 Million
Q2 2022

Aug 15, 2022

BUY
$33.54 - $55.0 $1.48 Million - $2.42 Million
44,044 Added 57.38%
120,809 $6.65 Million
Q1 2022

May 16, 2022

BUY
$31.02 - $48.18 $1.66 Million - $2.58 Million
53,585 Added 231.17%
76,765 $2.79 Million
Q4 2021

Feb 14, 2022

SELL
$41.14 - $56.98 $5.79 Million - $8.02 Million
-140,745 Reduced 85.86%
23,180 $1.08 Million
Q3 2021

Nov 15, 2021

BUY
$35.31 - $50.56 $3.81 Million - $5.46 Million
107,964 Added 192.93%
163,925 $8.29 Million
Q2 2021

Aug 16, 2021

SELL
$25.8 - $41.09 $14 Million - $22.2 Million
-540,753 Reduced 90.62%
55,961 $2.3 Million
Q1 2021

May 17, 2021

BUY
$23.55 - $32.4 $8.48 Million - $11.7 Million
360,065 Added 152.15%
596,714 $17.3 Million
Q4 2020

Feb 16, 2021

SELL
$25.8 - $32.39 $1.77 Million - $2.22 Million
-68,527 Reduced 22.45%
236,649 $6.66 Million
Q3 2020

Nov 16, 2020

BUY
$27.5 - $39.61 $7.56 Million - $10.9 Million
274,817 Added 905.22%
305,176 $9.42 Million
Q2 2020

Aug 14, 2020

BUY
$36.1 - $42.56 $1.1 Million - $1.29 Million
30,359 New
30,359 $1.29 Million

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $7.22B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.